SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001725160-21-000154
Filing Date
2021-06-30
Accepted
2021-06-30 16:51:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 zentalis-followxonprosupp6.htm 424B5 401634
2 image_0.jpg GRAPHIC 38416
  Complete submission text file 0001725160-21-000154.txt   454014
Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255769 | Film No.: 211062545
SIC: 2834 Pharmaceutical Preparations